Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib

Background: Development of radioresistance in oral squamous cell carcinoma (OSCC) remains a significant problem in cancer treatment, contributing to the lack of improvement in survival trends in recent decades. Effective strategies to overcome radioresistance are necessary to improve the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Liwei, Lam, Tiffany, Chen, Alex, Jensen, Caleb, Duncan, Leslie, Kong, Feng-Chong, Kurago, Zoya B., Shay, Chloe, Teng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140405/
https://www.ncbi.nlm.nih.gov/pubmed/32106632
http://dx.doi.org/10.3390/cells9030533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140405/
https://www.ncbi.nlm.nih.gov/pubmed/32106632
http://dx.doi.org/10.3390/cells9030533

Ejemplares similares